Pharmachem Laboratories Revenue and Competitors
Estimated Revenue & Valuation
- Pharmachem Laboratories's estimated annual revenue is currently $42.2M per year.
- Pharmachem Laboratories's estimated revenue per employee is $297,000
Employee Data
- Pharmachem Laboratories has 142 Employees.
- Pharmachem Laboratories grew their employee count by 0% last year.
Pharmachem Laboratories's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Purchasing Agent | Reveal Email/Phone |
2 | West Coast Account Representative III | Reveal Email/Phone |
3 | Infrastructure Network Engineer at Pharmachem Labs | Reveal Email/Phone |
Pharmachem Laboratories Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $107.3M | 534 | 9% | N/A | N/A |
What Is Pharmachem Laboratories?
Pharmachem Laboratories, Inc., is a leading manufacturer and supplier of value-added nutritional ingredients and bulk raw materials. We offer an exclusive list of trademarks and catalogue of products, as well as custom-manufacturing, and research and development services. Think of Pharmachem for all your nutritional ingredient needs.
keywords:N/A
N/A
Total Funding
142
Number of Employees
$42.2M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Pharmachem Laboratories News
ADM; BASF; Pharmachem Laboratories; Cargill; HSF Biotech. The market is categorized in the study based on. Soybean Oil Derived; Rapeseed Oil...
BASF; Pharmachem Laboratories; Cargill; HSF Biotech. The product may be classified into the following market segments based on its type: Soybean...
... Aloecorp Inc., Aloe Vera Australia, Natural Aloe Costa Rica S.A., Pharmachem Laboratories Inc., Terry Laboratories Inc.
Other Companies in Kearny
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $46.3M | 156 | 1% | N/A |
#2 | $37.4M | 162 | -1% | N/A |
#3 | $35M | 212 | -45% | N/A |
#4 | $77.6M | 215 | N/A | N/A |
#5 | $203.2M | 602 | 5% | N/A |